CDC45L peptides and vaccines including the same

Details for Australian Patent Application No. 2010253356 (hide)

Owner Oncotherapy Science, Inc.

Inventors Nishimura, Yasuharu; Tomita, Yusuke; Nakamura, Yusuke; Tsunoda, Takuya

Agent Davies Collison Cave

Pub. Number AU-A-2010253356

PCT Pub. Number WO2010/137295

Priority 61/217,133 26.05.09 US

Filing date 25 May 2010

Wipo publication date 2 December 2010

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 5/078 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells from blood or from the immune system

C12N 5/0783 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - T cells

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

1 December 2011 PCT application entered the National Phase

  PCT publication WO2010/137295 Priority application(s): WO2010/137295

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010253372-Air conditioning device specialized for heating

2010253344-Ion generating device for duct